[急性心力衰竭的住院利尿策略]
Simon Amar1, Antonio Leidi1,2, Sebastian Carballo1
1Service de médecine interne générale, Hôpitaux universitaires de Genève, 1211 Genève 14.
Revue medicale suisse
|October 23, 2025
概括
静脉注射富罗塞米德是急性心力衰竭的标准治疗方法,但可能无效. 新的和旧的利尿剂,如 thiazides,acetazolamide 和 SGLT2 抑制剂,为心脏衰竭提供了额外的治疗选择.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 急性心力衰竭是一种常见的医疗紧急情况.
- 静脉注射的罗西米德是主要的利尿疗法,尽管有来自安慰剂对照试验的有限证据.
- 富洛塞米德的疗效可能在某些患者中不足.
研究的目的:
- 审查急性心力衰竭的利尿治疗的不断变化的格局.
- 为突出替代性和辅助性利尿剂策略超出罗西米德.
主要方法:
- 对心脏衰竭的利尿疗法的文献综述.
- 分析支持新型和已确定的利尿剂的证据.
主要成果:
- 静脉注射富洛塞米德是当前的标准,但它有局限性.
- thiazides,acetazolamide,和-葡萄糖共运输体-2 (SGLT2) 抑制剂正在成为有价值的选择.
- 证据支持使用这些药物来治疗心脏衰竭患者.
结论:
- 治疗急性心力衰竭需要更广泛的利尿剂武器.
- 新的和旧的利尿剂提供替代品,当furosemide是不够的.
- 进一步的研究可能会巩固这些药物在心力衰竭管理中的作用.
相关概念视频
Heart Failure Drugs: Diuretics
796
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
796
Heart Failure V: Medical Management
215
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
215
Heart Failure VI: Adjunct Therapies
252
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
252
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
928
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
928
Acute Kidney Injury VI: Nursing Management
381
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
381
Acute Kidney Injury V: Interprofessional Care
295
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
295


